Skip to main content

Colgate-Palmolive Company (CL-N) Quote - Press Release

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

More stories below advertisement

Watch for Shares of Colgate-Palmoliv (CL) to Approach Resistance at $73.42

Comtex SmarTrend(R) - Fri Sep 27, 9:24AM CDT

Shares of Colgate-Palmoliv (NYSE:CL) opened today above their pivot of $72.69 and have already reached the first level of resistance at $73.09. Should the shares continue to rise, the resistance pivots of $73.42 and $74.15 will be of interest.

Over the past year, Colgate-Palmoliv has traded in a range of $57.41 to $76.41 and is now at $73.28, 28% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has declined 0.2%.

Colgate-Palmoliv (NYSE:CL) is currently priced 1.8% above its average consensus analyst price target of $71.95. The stock should find initial support at its 50-day moving average (MA) of $72.28 and further support at its 200-day MA of $68.87.

SmarTrend is tracking the current trend status for Colgate-Palmoliv and will alert subscribers who have CL in their portfolio or watchlist when shares have changed trend direction.

Write to SmarTrend at cs@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).